|
1
|
Mármol I, Sánchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18(pii): E1972017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bolocan A, Ion D, Ciocan DN and Paduraru
DN: Prognostic and predictive factors in colorectal cancer.
Chirurgia (Bucur). 107:555–563. 2012.PubMed/NCBI
|
|
3
|
De Rosa M, Rega D, Costabile V, Duraturo
F, Niglio A, Izzo P, Pace U and Delrio P: The biological complexity
of colorectal cancer: Insights into biomarkers for early detection
and personalized care. Therap Adv Gastroenterol. 9:861–886. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fumery M, Dulai PS, Gupta S, Prokop LJ,
Ramamoorthy S, Sandborn WJ and Singh S: Incidence, risk factors,
and outcomes of colorectal cancer in patients with ulcerative
colitis with low-grade dysplasia: A systematic review and
meta-analysis. Clin Gastroenterol Hepatol. 15:665–674.e5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coppedè F, Lopomo A, Spisni R and Migliore
L: Genetic and epigenetic biomarkers for diagnosis, prognosis and
treatment of colorectal cancer. World J Gastroenterol. 20:943–956.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Du Y, Liu X, Cho WC and Yang Y:
MicroRNAs as regulator of signaling networks in metastatic colon
cancer. Biomed Res Int. 2015:8236202015.PubMed/NCBI
|
|
7
|
Berretta M, Alessandrini L, De Divitiis C,
Nasti G, Lleshi A, Di Francia R, Facchini G, Cavaliere C, Buonerba
C and Canzonieri V: Serum and tissue markers in colorectal cancer:
State of art. Crit Rev Oncol Hematol. 111:103–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lech G, Slotwinski R and Krasnodebski IW:
The role of tumor markers and biomarkers in colorectal cancer.
Neoplasma. 61:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamazaki N, Koga Y, Taniguchi H, Kojima M,
Kanemitsu Y, Saito N and Matsumura Y: High expression of miR-181c
as a predictive marker of recurrence in stage II colorectal cancer.
Oncotarget. 8:6970–6983. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
13
|
Ruan K, Fang X and Ouyang G: MicroRNAs:
Novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giannakakis A, Coukos G, Hatzigeorgiou A,
Sandaltzopoulos R and Zhang L: miRNA genetic alterations in human
cancers. Expert Opin Biol Ther. 7:1375–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pagliuca A, Valvo C, Fabrizi E, di Martino
S, Biffoni M, Runci D, Forte S, De Maria R and Ricci-Vitiani L:
Analysis of the combined action of miR-143 and miR-145 on oncogenic
pathways in colorectal cancer cells reveals a coordinate program of
gene repression. Oncogene. 32:4806–4813. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wang K, Wang G, Ba Y, et al: Role of miR-143
targeting KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang G, Zhou H, Xiao H, Liu Z, Tian H and
Zhou T: MicroRNA-92a functions as an oncogene in colorectal cancer
by targeting PTEN. Dig Dis Sci. 59:98–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wan J, Xia L, Xu W and Lu N: Expression
and function of miR-155 in diseases of the gastrointestinal tract.
Int J Mol Sci. 17(pii): E7092016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou Y, Wang J, Wang X, Shi S, Wang W and
Chen Z: Appraising MicroRNA-155 as a noninvasive diagnostic
biomarker for cancer detection: A meta-analysis. Medicine
(Baltimore). 95:e24502016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan L, Yu J, Tan F, Ye GT, Shen ZY, Liu H,
Zhang Y, Wang JF, Zhu XJ and Li GX: SP1-mediated microRNA-520d-5p
suppresses tumor growth and metastasis in colorectal cancer by
targeting CTHRC1. Am J Cancer Res. 5:1447–1459. 2015.PubMed/NCBI
|
|
21
|
Wang JP: Chinese standard for the
diagnosis and treatment of colorectal cancer (2010). Zhonghua Wei
Chang Wai Ke Za Zhi. 14:1–4. 2011.(In Chinese). PubMed/NCBI
|
|
22
|
Binefa G, Rodriguez-Moranta F, Teule A and
Medina-Hayas M: Colorectal cancer: From prevention to personalized
medicine. World J Gastroenterol. 20:6786–6808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sideris M and Papagrigoriadis S: Molecular
biomarkers and classification models in the evaluation of the
prognosis of colorectal cancer. Anticancer Res. 34:2061–2068.
2014.PubMed/NCBI
|
|
24
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moridikia A, Mirzaei H, Sahebkar A and
Salimian J: MicroRNAs: Potential candidates for diagnosis and
treatment of colorectal cancer. J Cell Physiol. 233:901–913. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He B, Gao SQ, Huang LD, Huang YH, Zhang
QY, Zhou MT, Shi HQ, Song QT and Shan YF: MicroRNA-155 promotes the
proliferation and invasion abilities of colon cancer cells by
targeting quaking. Mol Med Rep. 11:2355–2359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Z, Yu L, Luo S, Li M, Li J, Li Q, Sun Y
and Wang C: miR-296 inhibits the metastasis and
epithelial-mesenchymal transition of colorectal cancer by targeting
S100A4. BMC Cancer. 17:1402017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang L, Dai DL, Su M, Martinka M, Li G and
Zhou Y: Aberrant expression of collagen triple helix repeat
containing 1 in human solid cancers. Clin Cancer Res. 12:3716–3722.
2006. View Article : Google Scholar : PubMed/NCBI
|
